JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A2754 TG100-115

Target: PI3K

Summary: PI3Kγ/PI3Kδ inhibitor

insoluble in H2O; insoluble in EtOH; ≥3.46 mg/mL
A2633 Brivanib Alaninate (BMS-582664)

Summary: VEGFR2 inhibitor,ATP-competitive

≥22.05 mg/mL
A5300 Ranolazine 2HCl

Summary: Partial fatty acid oxidation inhibitor

≥20.25 mg/mL
A5588 Oligomycin A
1 Citation

Target: Synthases/Synthetases

Summary: Mitochondrial ATP synthase Inhibitor
A5602 SB525334

Summary: (TGF-beta1) receptor inhibitor

≥34.3 mg/mL
A5220 Vecuronium Bromide

Target: AChR

Summary: Nonpolarizing neuromuscular relaxant

≥31.89 mg/mL
A5791 Ibuprofen Lysine

Summary: COX inhibitor

insoluble in EtOH; insoluble in DMSO; ≥17.62 mg/mL
A2024 PD168393

Target: PDGFR|FGFR|EGFR|PKC|insulin

Summary: EGFR inhibitor
A8301 GW788388

Summary: ALK5 inhibitor, potent and selective

≥21.25 mg/mL
A8334 Linsitinib
3 Citation

Summary: IGF1R/IR inhibitor,potent and novel

≥21.08 mg/mL